NPC1L1

NPC1 like intracellular cholesterol transporter 1, the group of Solute carrier family 65, NPC-type cholesterol transporters

Basic information

Region (hg38): 7:44512535-44541330

Links

ENSG00000015520NCBI:29881OMIM:608010HGNC:7898Uniprot:Q9UHC9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Ezetimibe, nonresponse toAD/ARPharmacogenomicVariants may have pharmacogenomic relevance and medication selection may be affected in patients with variantsGeneral15679830; 20686565

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the NPC1L1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the NPC1L1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
11
clinvar
6
clinvar
17
missense
75
clinvar
13
clinvar
7
clinvar
95
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
2
non coding
2
clinvar
2
Total 0 0 75 24 15

Variants in NPC1L1

This is a list of pathogenic ClinVar variants found in the NPC1L1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
7-44513457-C-T not specified Likely benign (Feb 14, 2023)2460246
7-44513458-G-A not specified Uncertain significance (Oct 20, 2021)2214814
7-44513513-A-C not specified Uncertain significance (Oct 06, 2021)2253380
7-44513605-C-T NPC1L1-related disorder Benign (Feb 21, 2019)3035704
7-44513634-G-A not specified Uncertain significance (Mar 29, 2022)2362904
7-44513639-A-G not specified Benign (Mar 29, 2016)403255
7-44513641-C-T not specified Likely benign (Aug 30, 2022)2400275
7-44513654-GGA-G NPC1L1-related disorder Benign (Feb 21, 2019)3035606
7-44515806-C-T not specified Uncertain significance (May 21, 2024)3300755
7-44515807-G-A not specified Benign (Mar 29, 2016)403256
7-44515822-G-A Likely benign (Jul 01, 2022)2657430
7-44515859-G-C not specified Uncertain significance (Jun 05, 2024)3300752
7-44515869-G-C not specified Uncertain significance (Sep 20, 2023)3201592
7-44515911-C-A not specified Uncertain significance (Feb 06, 2023)2455685
7-44515911-C-T not specified Uncertain significance (Mar 26, 2024)3300747
7-44515974-T-G not specified Benign (Mar 29, 2016)403257
7-44516085-G-T not specified Uncertain significance (Apr 09, 2024)3300757
7-44516100-A-T Ezetimibe response • not specified Likely benign (Mar 29, 2016)2621
7-44516704-G-A not specified Uncertain significance (Jan 18, 2022)2344382
7-44516768-T-C not specified Uncertain significance (Nov 14, 2023)3201591
7-44516876-G-T not specified Uncertain significance (Jul 25, 2023)2613641
7-44516910-C-G Likely benign (May 25, 2018)745816
7-44517233-G-T not specified Uncertain significance (May 17, 2023)2547134
7-44517235-C-A not specified Uncertain significance (Oct 30, 2023)3201590
7-44517235-C-G Benign (Jun 14, 2018)778302

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
NPC1L1protein_codingprotein_codingENST00000289547 2028781
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
2.31e-200.50712548802601257480.00103
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4097297610.9580.00004848765
Missense in Polyphen203234.210.866762817
Synonymous-1.443703361.100.00002222903
Loss of Function1.943954.40.7160.00000309579

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001950.00194
Ashkenazi Jewish0.000.00
East Asian0.006710.00671
Finnish0.00004680.0000462
European (Non-Finnish)0.0006360.000633
Middle Eastern0.006710.00671
South Asian0.0003930.000392
Other0.0006540.000652

dbNSFP

Source: dbNSFP

Function
FUNCTION: Plays a major role in cholesterol homeostasis. Is critical for the uptake of cholesterol across the plasma membrane of the intestinal enterocyte. Is the direct molecular target of ezetimibe, a drug that inhibits cholesterol absorption. Lack of activity leads to multiple lipid transport defects. The protein may have a function in the transport of multiple lipids and their homeostasis, and may play a critical role in regulating lipid metabolism. Acts as a negative regulator of NPC2 and down- regulates its expression and secretion by inhibiting its maturation and accelerating its degradation. {ECO:0000269|PubMed:15928087, ECO:0000269|PubMed:22095670}.;
Pathway
Fat digestion and absorption - Homo sapiens (human);Vitamin A and Carotenoid Metabolism;C21-steroid hormone biosynthesis and metabolism;Intestinal lipid absorption;Intestinal absorption;Digestion and absorption (Consensus)

Recessive Scores

pRec
0.187

Intolerance Scores

loftool
0.0150
rvis_EVS
1.38
rvis_percentile_EVS
94.54

Haploinsufficiency Scores

pHI
0.129
hipred
N
hipred_score
0.421
ghis
0.471

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.319

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Npc1l1
Phenotype
liver/biliary system phenotype; digestive/alimentary phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype;

Gene ontology

Biological process
cholesterol biosynthetic process;intestinal cholesterol absorption;cholesterol transport;lipoprotein metabolic process;response to drug;cellular response to sterol depletion;intestinal lipid absorption
Cellular component
plasma membrane;apical plasma membrane;cytoplasmic vesicle membrane;brush border membrane;spanning component of plasma membrane
Molecular function
protein binding;drug binding;Rab GTPase binding;myosin V binding